update on cael-101 from caelum biosciences
Published 3 years ago • 360 plays • Length 15:10Download video MP4
Download video MP3
Similar videos
-
10:31
cael-101 update
-
2:31
cael-101: a monoclonal antibody therapy for al amyloidosis
-
2:21
a phase 2, open-label study - safety, tolerability and efficacy of cael-101 in al amyloidosis pts
-
9:43
cael-101 ash annual meeting december 2020 oral presentation
-
1:02:21
arc talks webinar: clinical trial updates for the al community
-
1:11
current approaches for managing r/r al amyloidosis
-
34:44
updates on al amyloidosis treatment: what is new in 2023 | dana-farber cancer institute
-
5:14
current status & updates in the management of al amyloidosis
-
6:51
cael-101 ash annual meeting december 2020 poster presentation
-
1:20:49
update on diagnosis and treatment of al amyloidosis
-
3:55
chrysalis trial update in nsclc
-
26:59
updates on al amyloidosis treatment: what’s new in 2024
-
4:23
new organ response criteria for al amyloidosis
-
5:39
new organ response criteria in amyloidosis diagnosis
-
4:10
updates in al amyloidosis
-
2:41
the importance of early diagnosis for improved light chain amyloidosis survival
-
2:56
early vs. deferred transplantation in al amyloidosis